Nishida Hiroko 西田浩子

… Alternative Names

NISHIDA Hiroko 西田浩子

Less

Researcher Number	80317130
Other IDs
Affiliation (Current)	2025: 慶應義塾大学, 医学部(信濃町), 助教
Affiliation (based on the past Project Information) *help	2025: 慶應義塾大学, 医学部(信濃町), 助教 2018 – 2023: 慶應義塾大学, 医学部(信濃町), 助教 2017: 慶應義塾大学, 医学部, 助教 2016: 慶應義塾大学, 医学部(信濃町), 助教 2016: 慶應義塾大学, 医学部(信濃町), 特任助教 2015: 慶應義塾大学, 医学部, 助教 2013 – 2014: 慶應義塾大学, 医学部, 特任助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Medium-sized Section 49:Pathology, infection/immunology, and related fields / Tumor therapeutics / Human pathology
Keywords	Principal Investigator 多発性骨髄腫 / モノクローナル抗体 / ヒト化抗CD26モノクローナル抗体 / CD26 / HDAC阻害 / 血管内皮細胞 / 破骨細胞 / エピジェネテイックス / ヒト化モノクローナル抗体 / CAR-T細胞 … More / 非ヒストン蛋白 / HDACアイソフォーム / CD26陰性骨髄腫 / Treg / MDSC / NK細胞 / ヒストン脱アセチル化酵素 / 抗体 / HDAC / 腫瘍免疫回避 / エピジェネテイック制御 / アセチル化 / Sp1 / c-Myc / アイソフォーム / ヒストン脱アセチル化酵素(HDAC) / 新規分子標的療法 / 間質細胞 / 分子標的療法 / 骨髄腫モデルマウス / 直接的効果 / 骨髄間質細胞 / SP分画 / 骨髄腫細胞 / 骨髄微小環境 / SP細胞 / 新規薬剤 / ADCC / 血液内科 / p38 MAPK / 溶骨性骨腫瘍 / TRAP / 溶骨性骨転移 / 骨吸収 / mi/Mitf / p38MAPK / 破骨前駆細胞 … More Except Principal Investigator がん / スーパーエンハンサー / RNAポリメラーゼII / 核移行 / CD26 / Antibody-Drug Conjugate / 抗体療法 / 抗体抗がん剤結合薬ADC / 分子標的療法 / 抗体 / ChIPseq法 / 病理検体 / FFPE / モノクローナル抗体 / クロマチン免疫沈降塩基配列決定法 / ホルマリン固定パラフィン包埋組織 / RNAポリメラーゼⅡ / 抗体薬物複合体 / アレルギー・ぜんそく / 自然免疫 / メタボリック症候群 / 免疫学 / 病理学 Less

Development of novel CD26-targeting chimeric antigen receptor cell therapy in relapsed or refractory multiple myelomaPrincipal Investigator
- Principal Investigator
  
  西田浩子
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Keio University
The role of HDAC isoform regulating CD26 induction in relapsed or refractory multiple myelomaPrincipal Investigator
- Principal Investigator
  
  西田浩子
- Project Period (FY)
  2020 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Keio University
Development of ChIPseq method using pathological specimens and identification of disease-specific super-enhancer
- Principal Investigator
  
  Yamada Taketo
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 49:Pathology, infection/immunology, and related fields
- Research Institution
  Saitama Medical University
Novel anti-cancer therapy against super-enhancer using humanized monoclonal antibody with transportation activity into nucleus
- Principal Investigator
  
  YAMADA TAKETO
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Saitama Medical University
Novel therapy against human cancers using intra-nuclear transportable humanized monoclonal antibody against CD26.
- Principal Investigator
  
  YAMADA TAKETO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Saitama Medical University
Molecular-targeted therapy by humanized anti-CD26 monoclonal antibody in relapsed or refractory multiple myelomaPrincipal Investigator
- Principal Investigator
  
  NISHIDA Hiroko
- Project Period (FY)
  2016 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Keio University
Development of novel molecular-targeted therapy by humanized anti-CD26 monoclonal antibody in refractory osteolytic bone metastasisPrincipal Investigator
- Principal Investigator
  
  NISHIDA HIROKO Nishida
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Keio University
Human natural helper cells and its involvement in diseases
- Principal Investigator
  
  YAMADA TAKETO
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Human pathology
- Research Institution
  Keio University

All 2024 2022 2021 2019 2018 2017 2016 2015 2014 2013 Other

All Journal Article Presentation Book

[Book] 目でみるトレーニング第2集2013
- Author(s)
  西田浩子
- Publisher
  医学書院
- Data Source
  KAKENHI-PROJECT-25430157
[Journal Article] HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation2024
- Author(s)
  Nishida H, Suzuki R, Nakajima K, Hayashi M, Morimoto C, Yamada T
- Journal Title
  
  Cancer Res Commun
  
  Volume: 4(2) Issue: 2 Pages: 349-364
- DOI
  10.1158/2767-9764.crc-23-0215
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07682, KAKENHI-PROJECT-22K19387, KAKENHI-PROJECT-23K27395
[Journal Article] Rapid progress in immunotherapies for multiple myeloma2021
- Author(s)
  Hiroko Nishida
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 11 Pages: 2712-2712
- DOI
  10.3390/cancers13112712
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07682
[Journal Article] Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor rrowth via impairing mRNA synthesis2019
- Author(s)
  Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Yanagawa H, Yamada T
- Journal Title
  
  Cancers
  
  Volume: 11 Issue: 8 Pages: 1138-1138
- DOI
  10.3390/cancers11081138
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K22542, KAKENHI-PROJECT-18K15253, KAKENHI-PROJECT-19H03519
[Journal Article] 2. Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor growth via impairing RNA synthesis.2019
- Author(s)
  Hayashi M, Nishida H, Morimoto C, Sakamoto M, Yamada T, et al.
- Journal Title
  
  Cancers
  
  Volume: 11(1138) Pages: 1-21
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] 1. Monoclonal antibody therapies in multiple myeloma: a chalenge to develop novel targets.2019
- Author(s)
  Nishida H Yamada T
- Journal Title
  
  J Oncol
  
  Volume: 6084012 Pages: 1-10
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets2019
- Author(s)
  Nishida H, Yamada T
- Journal Title
  
  Journal of Oncology
  
  Volume: 2019 Pages: 6084012-6084012
- DOI
  10.1155/2019/6084012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K22542, KAKENHI-PROJECT-19H03519
[Journal Article] Primary Isolated Bone Marrow Diffuse Large B cell Lymphoma with Long Term Complete Remission2018
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Masao Hori, Katsuyuki Obara
- Journal Title
  
  Leukemia Research Reports
  
  Volume: 10 Pages: 11-15
- DOI
  10.1016/j.lrr.2018.05.004
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] Bone Targeted Therapy in Multiple Myeloma2018
- Author(s)
  Hiroko Nishida
- Journal Title
  
  International Journal of Hematological Disorders
  
  Volume: 3 Pages: 3-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma2018
- Author(s)
  Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Journal Title
  
  Blood Cancer Journal
  
  Volume: 8(99) Issue: 11 Pages: 1-17
- DOI
  10.1038/s41408-018-0127-y
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180, KAKENHI-PROJECT-16H04714, KAKENHI-PROJECT-16H05345
[Journal Article] Bone-targeted agents in multiple myeloma2018
- Author(s)
  Hiroko Nishida
- Journal Title
  
  Hematology Reports
  
  Volume: 10 Issue: 1 Pages: 11-16
- DOI
  10.4081/hr.2018.7401
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] Bone targeted therapy in multiple myeloma2017
- Author(s)
  Hiroko Nishida
- Journal Title
  
  International Journal of Hematological Disorders
  
  Volume: 3 Pages: 3-6
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180
[Journal Article] A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition.2016
- Author(s)
  Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Yamada T.
- Journal Title
  
  Cancer Cell International
  
  Volume: 30 Issue: 1 Pages: 35-35
- DOI
  10.1186/s12935-016-0310-9
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H04714, KAKENHI-PROJECT-16H05345, KAKENHI-PROJECT-16K07180
[Journal Article] Isolated central nervous system relapse in type II enteropathy-associated T cell lymphoma2015
- Author(s)
  西田浩子、遠藤聖、波多野まみ、立川伸雄、間嶋絵梨、橋田里妙、堀眞佐男、小原克之
- Journal Title
  
  Rinsho Ketsueki
  
  Volume: 56 Issue: 6 Pages: 692-698
- DOI
  10.11406/rinketsu.56.692
- NAID
  130005093090
- ISSN
  0485-1439, 1882-0824
- Language
  Japanese
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25430157
[Journal Article] Blockade of CD26 Signaling Inhibits Human Osteoclast Development2014
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Journal Title
  
  Journal of Bone and Mineral Resarch
  
  Volume: 29 Issue: 11 Pages: 2439-2455
- DOI
  10.1002/jbmr.2277
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25430157
[Journal Article] Optic Nerve Involvement of Waldenstrom's Macroglobulinemia - with Autopsy Findings2014
- Author(s)
  Hiroko Nishida, Risa Hashida, Mami Hatano, Masao Hori, Katsuyuki Obara
- Journal Title
  
  Neurological Sciences
  
  Volume: 35 Pages: 1299-1302
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430157
[Journal Article] Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription2013
- Author(s)
  Yamada K, Hayashi M, Madokoro H, Nishida H, Du W, Ohnuma K, Sakamoto M, Morimoto C, Yamada T
- Journal Title
  
  PLoS One
  
  Volume: 8 Issue: 4 Pages: e62304-e62304
- DOI
  10.1371/journal.pone.0062304
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21679005, KAKENHI-PROJECT-24659401, KAKENHI-PROJECT-25430157, KAKENHI-PROJECT-25670195
[Journal Article] A Report of 2 cases of Disseminated Invasive Aspergillosis with Myocarditis in Immunocompromised Patients2013
- Author(s)
  Tetsuhiro Yoshino, Hiroko Nishida, Michihiro Sakauchi, Masanori Nemoto, Mami Hatano, Kazuyuki Koyama, Masao, Hori, Katsuyuki Obara
- Journal Title
  
  OJPathology
  
  Volume: 3 Issue: 04 Pages: 166-169
- DOI
  10.4236/ojpathology.2013.34030
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] HDAC inhibition involves CD26 induction on multiple myeloma cells via the c-Myc/Sp1-mediated promoter activation and overcomes therapeutic resistance by humanized antibody.2022
- Author(s)
  Hiroko Nishida, Reiko Suzuki, Kiyora Nakajima, Mutsumi Hayashi, Michiie Sakamoto
- Organizer
  64th ASH Annual Meeting & Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07682
[Presentation] HDAC inhibition involves CD26 induction in myeloma cells via the Sp1-mediated promoter activation.2022
- Author(s)
  Hiroko Nishida, Reiko Suzuki, Mutsumi Hayashi, Michiie Sakamoto
- Organizer
  84th Japanese Society of Hematology Annual Meeting
- Data Source
  KAKENHI-PROJECT-20K07682
[Presentation] Up-regulation of CD26 on myeloma cells by HDAC inhbition enhances the efficacy of humanized antibody2021
- Author(s)
  Nishida Hiroko, Mari Fujiwara, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  The 83rd Japanese Society of Hematology, Annual Meeting
- Data Source
  KAKENHI-PROJECT-20K07682
[Presentation] Up-regulation of CD26 on multiple myeloma cells by HDAC inhibition augments the efficacy of humanized antibody2021
- Author(s)
  Hiroko Nishida, Reiko Suzuki, Mari Fujiwara, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  The 63rd AMERICAN SOCIETY OF HEMATOLOGY(ASH) ANNUAL MEETING
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03519
[Presentation] Humanized anti-CD26 monoclonal antibody targets clonogenic side population cells in multiple myeloma2019
- Author(s)
  Nishida H, Yamada T
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19H03519
[Presentation] Humanized anti-CD26 monoclonal antibody clonogenic side population cells in multiple myeloma.2019
- Author(s)
  Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] CD26 is a potential therapeutic target by humanized monoclonal antibody in multiple myeloma.2019
- Author(s)
  Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
- Organizer
  第108回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Humanized anti-CD26 monoclonal antibody targets clonogenic side population cells in multiple myeloma2019
- Author(s)
  Nishida H, Yamada T
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-19K22542
[Presentation] Anti-CD26 humanized antibody-triptolide conjugate moves into nucleus and impairs RNA polymerase II.2018
- Author(s)
  Yamada T, Madokoro H, Yamada K, Nishida H,　Morimoto C,　Sakamoto M, Hayashi M.
- Organizer
  第107回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] CD26 is a potential therapeutic target by humanized monoclonal antibody in multiple myeloma2018
- Author(s)
  Hiroko Nishida, Mustumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  23rd Congress of the European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] ヒト化抗CD26抗体とTriptolideの抗体薬物複合体はRNA polymeraseを阻害する2018
- Author(s)
  林　睦、間所　裕子、山田　幸司、西田　浩子、森本　幾夫、坂元　亨宇、山田　健人
- Organizer
  第107回病理学会総会
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Anti-CD26 Humanized Monoclonal Antibody Conjugated To Triptolide Inhibits Mesothelioma Cell Growth Via Transportation Into Nucleus And Impaired RNA Polymerase II.2018
- Author(s)
  Yamada T, Madokoro H, Yamada K, Nishida H,　Morimoto C,　Sakamoto M, Hayashi M.
- Organizer
  The 6th JCA-AACR Special Joint Conference, The Latest Advances in Lung Cancer Research: From Basic Science to Therapeutics
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Anti-tumor effects of humanized anti-CD26 monoclonal antibody against hepatocellular carcinoma.2017
- Author(s)
  Yamada T, Madokoro H, Yamada K, Nishida H,　Morimoto C,　Sakamoto M, Hayashi M.
- Organizer
  第106回日本病理学会総会（東京）
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Humanized anti-CD26 monoclonal antibody has therapeutic potential in osteolytic bone metastasis2017
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michiie Sakamoto, Taketo Yamada
- Organizer
  15th Japanese Society of Medical Oncology Annual Meeting
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Novel Monoclonal Antibody Therapy Targeting CD26 in Multiple Myeloma.2017
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michiie Sakamoto, Taketo Yamada
- Organizer
  22nd Congress, European Hematology Association
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Humanized anti-CD26 monoclonal antibody has a therapeutic potentiality against multiple myeloma2017
- Author(s)
  Hiroko Nishida, Mustumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  79th Annual Meeting of the Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Humanized anti-CD26 monoclonal antibody, YS110, has anti-myeloma efficacy for the treatment of high-risk multiple myeloma2017
- Author(s)
  Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
- Organizer
  the 59th American Society of Hematology Annual Meeting and Exposition. (Atlanta, USA)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Humanized anti-CD26 monoclonal antibody has a therapeutic potentiality against multiple myeloma.2017
- Author(s)
  Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
- Organizer
  第79回日本血液学会総会（東京）
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Humanized anti-CD26 monoclonal antibody has anti-myeloma efficacy for the treatment of multiple myeloma2017
- Author(s)
  Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto,Michiie Sakamoto, Taketo Yamada
- Organizer
  59th American Society of Hematology Annual Meeting & Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] 肝癌に対するヒト化抗CD26モノクローナル抗体の抗腫瘍効果2017
- Author(s)
  山田健人、西田浩子、林睦、間所裕子、坂元亨宇
- Organizer
  第106回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Anti-CD26 humanized monoclonal antibody conjugated to triptolide is transported into nucleus and impairs RNA polymerase II.2017
- Author(s)
  Yamada T, Madokoro H, Nishida H,Morimoto C,Sakamoto M, Hayashi M.
- Organizer
  2017年度生命科学系学会合同年次大会（ConBio2017）（神戸）
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Humanized anti-CD26 monoclonal antibody has therapeutic potential in multiple myeloma2017
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Mutsumi Hayashi, Michie Sakamoto, Taketo Yamada
- Organizer
  第57回リンパ網内系学会総会.
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Isolated central nervous system relapse in type II enteropathy-associated T cell lymphoma2017
- Author(s)
  Hiroko Nishida, Eri Mashima, Mami Hatano, masao Hori, Katsuyuki Obara
- Organizer
  78th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  パシフィコ横浜、横浜
- Year and Date
  2017-10-13
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] ヒト化抗CD26モノクローナル抗体とRNAポリメラーゼII阻害剤トリプトライドの複合体の抗腫瘍効果2016
- Author(s)
  林睦、間所裕子、西田浩子、坂本亨宇、山田健人
- Organizer
  第105回日本病理学会総会
- Place of Presentation
  仙台国際会議場、仙台
- Year and Date
  2016-05-12
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] Humanized anti-CD26 antibody conjugated with RNA polymerase II inhibitor Triptolide suppresses tumor2016
- Author(s)
  林睦、間所裕子、山田幸司、西田浩子、坂元亨宇、森本幾夫、山田健人
- Organizer
  第105回日本病理学会総会
- Place of Presentation
  仙台国際センター
- Year and Date
  2016-05-12
- Data Source
  KAKENHI-PROJECT-16H04714
[Presentation] Isolated central nervous system relapse in type II enteropathy-associated T cell lymphoma2016
- Author(s)
  Hiroko Nishida, Eri Massima, mami Habano, Masao Hori, Katsumyuki Obara
- Organizer
  14th the Japanese Society of Medical Oncology Annual Meeting
- Place of Presentation
  神戸国際会議場、神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-16K07180
[Presentation] CD26 is a novel target for the treatment of tumor progression and its related osteolytic bone disease.2015
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  57th American Society of Hematology Annual Meeting and Exposition
- Place of Presentation
  オーランド（アメリカ）
- Year and Date
  2015-12-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] 破骨細胞による骨髄腫細胞のCD26発現誘導と細胞増殖・生存の亢進～ヒト化抗CD26抗体療法を目指して2015
- Author(s)
  西田浩子、間所裕子、林睦、坂本亨宇、山田健人
- Organizer
  第104回日本病理学会総会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-05-02
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Blockade of CD26 signaling using humanized antibody reduces myeloma cell growth and its bone disease.2015
- Author(s)
  Hiroko Nishida, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  77th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  石川県立音楽堂・ホテル日航金沢（石川県金沢市）
- Year and Date
  2015-10-18
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] 経腸栄養中に銅欠乏性貧血をきたした一例2015
- Author(s)
  間嶋絵梨、西田浩子、小原克之
- Organizer
  第203回日本内科学会茨城地方会
- Place of Presentation
  茨城県立健康プラザ (茨城県水戸市)
- Year and Date
  2015-03-14
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Optic nerve involvement of Waldenstrom's macroglobulinemia2015
- Author(s)
  Hiroko Nishida, Risa Hashida, Mami Hatano, Masao Hori, Katsuyuki Obara
- Organizer
  77th Annual Meeting of the Japanese Society of Hematology
- Place of Presentation
  石川県立音楽堂・ホテル日航金沢（石川県金沢市）
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Antitumor activity of anti-CD26 humanized monoclonal antibody conjugated with triptlide via intranuclear transportation2015
- Author(s)
  Mustumi Hayashi, Kohji Yamada, Hiroko Nishida, Michiie Sakamoto, Chikao Morimoto, Taketo Yamada
- Organizer
  74th Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-10
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] CD26 Signaling Involves Human Functional Osteoclast Development2013
- Author(s)
  Yamada T, Nishida H, Madokoro H
- Organizer
  第36 回日本分子生物学会年会
- Place of Presentation
  神戸国際会議場（兵庫県）
- Data Source
  KAKENHI-PROJECT-23390086
[Presentation] Humanized Anti-CD26 Monoclonal Antibody Inhibits Osteoclast Bone Resorption Activity via Blockade of P38MAPK Signaling in Multiple Myeloma2013
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
- Organizer
  55th American Society of Hematology Annual Meeting and Exposition
- Place of Presentation
  New Orleans Ernest N. Morial Conventin Center
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Blockade of CD26 Signaling Impairs Human Osteoclast Development2013
- Author(s)
  Hiroko Nishida, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, Kohji Yamada, Michiie Sakamoto, Chikao Morimoto, Taketo Yamada
- Organizer
  75th Japanese Society of Hematology
- Place of Presentation
  ロイトン札幌
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] CD26 Signaling Involves Human Functional Osteoclast Development2013
- Author(s)
  Taketo Yamada, Hiroko Nishida, Hiroko Madokoro
- Organizer
  第36回日本分子生物学会年会
- Place of Presentation
  神戸国際会議場
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] ヒト化抗CD26モノクローナル抗体によるヒト破骨細胞分化抑制
- Author(s)
  西田浩子、林　睦、坂元亨宇、山田健人
- Organizer
  第103回日本病理学会総会
- Place of Presentation
  広島国際会議場、ANAクラウンプラザホテル広島 (広島県広島市）
- Year and Date
  2014-04-24 – 2014-04-26
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Sustained complete remission in a patient with primary B-cell lymphoma of the caudal equina
- Author(s)
  Hiroko Nishida, Masao Hori, Mami Hatano, Keiji Yamaguchi, Katsuyuki Obara
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場 (大阪府大阪市）
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Humanized anti-CD26 monoclonal antibody blocks osteoclast differentiation in multiple myeloma
- Author(s)
  Hiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, Mutsumi Hayashi, Michiie Sakamoto, Chikao Morimoto, Taketo Yamada
- Organizer
  第76回日本血液学会学術集会
- Place of Presentation
  大阪国際会議場 (大阪府大阪市）
- Year and Date
  2014-10-31 – 2014-11-02
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] Targeting CD26 on both osteoclast and tumor cell in osteolytic bone metastasis with humanized anti-CD26 monoclonal antibody.
- Author(s)
  Hiroko Nishida, Chikao Morimoto, Michiie, Sakamoto, Taketo, Yamada
- Organizer
  第73回日本癌学会学術集会
- Place of Presentation
  パシフィコ横浜 (神奈川県神奈川市)
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25430157
[Presentation] 肝・骨髄浸潤で発症したMyC/IgH陽性び漫性大細胞型B細胞性リンパ腫の一例
- Author(s)
  橋田里妙、西田浩子、鈴木孝治、堀眞佐男、小原克之
- Organizer
  第599回日本内科学会関東地方会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-25430157

1. YAMADA TAKETO (60230463)

# of Collaborated Projects: 7 results

# of Collaborated Products: 41 results
2. HAYASHI Mutsumi (60327575)

# of Collaborated Projects: 4 results

# of Collaborated Products: 9 results
3. 山田幸司 (90570979)

# of Collaborated Projects: 2 results

# of Collaborated Products: 10 results
4. OHNUMA Kei

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nishida Hiroko 西田 浩子

NISHIDA Hiroko 西田 浩子

Research Projects

Research Products

Co-Researchers

Development of novel CD26-targeting chimeric antigen receptor cell therapy in relapsed or refractory multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The role of HDAC isoform regulating CD26 induction in relapsed or refractory multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of ChIPseq method using pathological specimens and identification of disease-specific super-enhancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel anti-cancer therapy against super-enhancer using humanized monoclonal antibody with transportation activity into nucleus

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel therapy against human cancers using intra-nuclear transportable humanized monoclonal antibody against CD26.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular-targeted therapy by humanized anti-CD26 monoclonal antibody in relapsed or refractory multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel molecular-targeted therapy by humanized anti-CD26 monoclonal antibody in refractory osteolytic bone metastasisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Human natural helper cells and its involvement in diseases

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 目でみるトレーニング第2集2013

Author(s)

Publisher

Data Source

[Journal Article] HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Rapid progress in immunotherapies for multiple myeloma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor rrowth via impairing mRNA synthesis2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 2. Novel antibody-drug conjugate with anti-CD26 humanized monoclonal antibody and transcription factor IIH (TFIIH) inhibitor, triptolide, inhibits tumor growth via impairing RNA synthesis.2019

Author(s)

Journal Title

Data Source

[Journal Article] 1. Monoclonal antibody therapies in multiple myeloma: a chalenge to develop novel targets.2019

Author(s)

Journal Title

Data Source

Nishida Hiroko 西田浩子

NISHIDA Hiroko 西田浩子